BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27879217)

  • 1. Generation of optic atrophy 1 patient-derived induced pluripotent stem cells (iPS-OPA1-BEHR) for disease modeling of complex optic atrophy syndromes (Behr syndrome).
    Hauser S; Schuster S; Theurer Y; Synofzik M; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):426-429. PubMed ID: 27879217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leigh-like neuroimaging features associated with new biallelic mutations in OPA1.
    Rubegni A; Pisano T; Bacci G; Tessa A; Battini R; Procopio E; Giglio S; Pasquariello R; Santorelli FM; Guerrini R; Nesti C
    Eur J Paediatr Neurol; 2017 Jul; 21(4):671-677. PubMed ID: 28442211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1.
    Lee J; Jung SC; Hong YB; Yoo JH; Koo H; Lee JH; Hong HD; Kim SB; Chung KW; Choi BO
    Mol Med Rep; 2016 Jul; 14(1):33-40. PubMed ID: 27150940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-onset Behr syndrome due to compound heterozygous mutations in OPA1.
    Bonneau D; Colin E; Oca F; Ferré M; Chevrollier A; Guéguen N; Desquiret-Dumas V; N'Guyen S; Barth M; Zanlonghi X; Rio M; Desguerre I; Barnerias C; Momtchilova M; Rodriguez D; Slama A; Lenaers G; Procaccio V; Amati-Bonneau P; Reynier P
    Brain; 2014 Oct; 137(Pt 10):e301. PubMed ID: 25012220
    [No Abstract]   [Full Text] [Related]  

  • 5. Behr syndrome with homozygous C19ORF12 mutation.
    Kleffner I; Wessling C; Gess B; Korsukewitz C; Allkemper T; Schirmacher A; Young P; Senderek J; Husstedt IW
    J Neurol Sci; 2015 Oct; 357(1-2):115-8. PubMed ID: 26187298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous OPA1 mutations in Behr syndrome.
    Marelli C; Amati-Bonneau P; Reynier P; Layet V; Layet A; Stevanin G; Brissaud E; Bonneau D; Durr A; Brice A
    Brain; 2011 Apr; 134(Pt 4):e169; author reply e170. PubMed ID: 21112924
    [No Abstract]   [Full Text] [Related]  

  • 7. Generation of a human iPSC line from a patient with an optic atrophy 'plus' phenotype due to a mutation in the OPA1 gene.
    Galera-Monge T; Zurita-Díaz F; Moreno-Izquierdo A; Fraga MF; Fernández AF; Ayuso C; Garesse R; Gallardo ME
    Stem Cell Res; 2016 May; 16(3):673-6. PubMed ID: 27346197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5).
    Hauser S; Höflinger P; Theurer Y; Rattay TW; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):437-440. PubMed ID: 27879220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous R486C mutation in CYP7B1 (SPG5).
    Höflinger P; Theurer Y; Schüle R; Schöls L; Hauser S
    Stem Cell Res; 2016 Sep; 17(2):422-425. PubMed ID: 27879216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of SPAST mutant induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia (HSP) patient.
    Hauser S; Erzler M; Theurer Y; Schuster S; Schüle R; Schöls L
    Stem Cell Res; 2016 Nov; 17(3):485-488. PubMed ID: 27789400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent OPA1 mutation and chromosome 3q deletion leading to Behr syndrome: a case report.
    Zeng T; Liao L; Guo Y; Liu X; Xiong X; Zhang Y; Cen S; Li H; Wei S
    BMC Pediatr; 2020 Sep; 20(1):420. PubMed ID: 32883255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an induced pluripotent stem cell line BIOi002-A from a patient with autosomal dominant optic atrophy.
    Zhang XH; Xie Y; Xu K; Li Y
    Stem Cell Res; 2021 May; 53():102278. PubMed ID: 33752025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1.
    Tubsuwan A; Pires C; Rasmussen MA; Schmid B; Nielsen JE; Hjermind LE; Hall V; Nielsen TT; Waldemar G; Hyttel P; Clausen C; Kitiyanant N; Freude KK; Holst B
    Stem Cell Res; 2016 Jan; 16(1):110-2. PubMed ID: 27345792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation.
    Höflinger P; Hauser S; Theurer Y; Weißenberger S; Wilke C; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):433-436. PubMed ID: 27879219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1.
    Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Hyttel P; Freude KK
    Stem Cell Res; 2016 Mar; 16(2):229-32. PubMed ID: 27345973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1.
    Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Holst B; Hyttel P; Freude KK
    Stem Cell Res; 2016 Mar; 16(2):334-7. PubMed ID: 27345998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1.
    Jung-Klawitter S; Ebersold J; Göhring G; Blau N; Opladen T
    Stem Cell Res; 2017 Apr; 20():38-41. PubMed ID: 28395739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration-free erythroblast-derived human induced pluripotent stem cells (iPSCs) from an individual with Ataxia-Telangiectasia (A-T).
    Bhatt N; Ghosh R; Roy S; Gao Y; Armanios M; Cheng L; Franco S
    Stem Cell Res; 2016 Sep; 17(2):205-207. PubMed ID: 27879207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
    Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
    Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of human induced pluripotent stem cell line from a patient with a long QT syndrome type 2.
    Fatima A; Ivanyuk D; Herms S; Heilmann-Heimbach S; O'Shea O; Chapman C; Izsvák Z; Farr M; Hescheler J; Šarić T
    Stem Cell Res; 2016 Mar; 16(2):304-7. PubMed ID: 27345990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.